中国当代医药
中國噹代醫藥
중국당대의약
PERSON
2014年
25期
69-71
,共3页
潘毅%何飞民%孙贵才%夏芝辉%韩飚%闫智杰
潘毅%何飛民%孫貴纔%夏芝輝%韓飚%閆智傑
반의%하비민%손귀재%하지휘%한표%염지걸
脓毒症%肾损伤%低分子肝素
膿毒癥%腎損傷%低分子肝素
농독증%신손상%저분자간소
Sepsis%Kidney injury%Low molecular heparin
目的:观察低分子肝素对脓毒症患者急性肾损伤的疗效及预后的影响。方法选取30例脓毒症合并肾损伤的患者,随机分为治疗组和对照组,对照组常规给予抗感染、呼吸支持、营养支持等治疗,治疗组给予低分子肝素针皮下注射,观察患者治疗后第3、7天肾功能胱抑素C(CysC)、血清肌酐(SCr)等的变化情况,并统计28 d生存率。结果治疗组患者治疗后第3、7天CysC水平与对照组比较,差异有统计学意义(P<0.01);SCr治疗后第3天与对照组比较,差异无统计学意义(P>0.05),第7天与对照组比较,差异有统计学意义(P<0.05);两组急性生理及慢性健康评分Ⅱ(APACHEⅡ评分)比较,差异无统计学意义(P>0.05);治疗组生存11例,对照组生存9例;两组生存患者的CysC差异无统计学意义,而对照组死亡患者的CysC明显高于治疗组(P<0.05)。结论低分子肝素治疗脓毒症急性肾损伤,可减轻脓毒症肾损伤程度,改善肾功能,并在一定程度上影响预后。
目的:觀察低分子肝素對膿毒癥患者急性腎損傷的療效及預後的影響。方法選取30例膿毒癥閤併腎損傷的患者,隨機分為治療組和對照組,對照組常規給予抗感染、呼吸支持、營養支持等治療,治療組給予低分子肝素針皮下註射,觀察患者治療後第3、7天腎功能胱抑素C(CysC)、血清肌酐(SCr)等的變化情況,併統計28 d生存率。結果治療組患者治療後第3、7天CysC水平與對照組比較,差異有統計學意義(P<0.01);SCr治療後第3天與對照組比較,差異無統計學意義(P>0.05),第7天與對照組比較,差異有統計學意義(P<0.05);兩組急性生理及慢性健康評分Ⅱ(APACHEⅡ評分)比較,差異無統計學意義(P>0.05);治療組生存11例,對照組生存9例;兩組生存患者的CysC差異無統計學意義,而對照組死亡患者的CysC明顯高于治療組(P<0.05)。結論低分子肝素治療膿毒癥急性腎損傷,可減輕膿毒癥腎損傷程度,改善腎功能,併在一定程度上影響預後。
목적:관찰저분자간소대농독증환자급성신손상적료효급예후적영향。방법선취30례농독증합병신손상적환자,수궤분위치료조화대조조,대조조상규급여항감염、호흡지지、영양지지등치료,치료조급여저분자간소침피하주사,관찰환자치료후제3、7천신공능광억소C(CysC)、혈청기항(SCr)등적변화정황,병통계28 d생존솔。결과치료조환자치료후제3、7천CysC수평여대조조비교,차이유통계학의의(P<0.01);SCr치료후제3천여대조조비교,차이무통계학의의(P>0.05),제7천여대조조비교,차이유통계학의의(P<0.05);량조급성생리급만성건강평분Ⅱ(APACHEⅡ평분)비교,차이무통계학의의(P>0.05);치료조생존11례,대조조생존9례;량조생존환자적CysC차이무통계학의의,이대조조사망환자적CysC명현고우치료조(P<0.05)。결론저분자간소치료농독증급성신손상,가감경농독증신손상정도,개선신공능,병재일정정도상영향예후。
Objective To observe the effect and prognostic impact of low molecular heparin in sepsis patients with a-cute kidney injury. Methods 30 cases of sepsis patients with combined renal injury were selected and randomly divid-ed into treatment group and control group,the control group was given routine anti-infection,respiratory support,and nu-tritional support treatment,the treatment group was given low molecular heparin subcutaneous injection needle,the change of renal function cystatin C (CysC),serum creatinine (SCr) so on in 3 and 7 days after treatment were observed, the survival rate of 28 days were counted. Results The CysC level in in 3 and 7 days after treatment of treatment group compared with the control group,the difference was statistically significant (P<0.01),but the SCr in 3 days after treat-ment compared with the control group,there was no statistically significant difference (P>0.05),the 3 days after treatment compared with the control group,the difference was statistically significant (P<0.05).The acute physiology and chronic health evaluation II (APACHE II score) between the two groups,there was no statistically significant difference (P>0.05).The treatment group survival in 11 cases,9 cases in control group,the CysC in survival patients of two groups with no statistical significance,while the CysC in death patients of control group was significantly higher than that of treat-ment group (P<0.05). Conclusion Low molecular heparin in the treatment of sepsis patients with acute renal injury can reduce sepsis renal damage degree,and improve renal function and to a certain extent affect the prognosis.